Effects of ethnicity and socioeconomic status on surgical outcomes from inflammatory bowel disease.


Journal

International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899

Informations de publication

Date de publication:
Jun 2022
Historique:
accepted: 01 05 2022
pubmed: 14 5 2022
medline: 9 6 2022
entrez: 13 5 2022
Statut: ppublish

Résumé

Evidence suggests that ethnicity and socioeconomic status of patients with chronic diseases influence their healthcare outcomes. The aim of this study was to assess the impact of these factors on the surgical outcome of patients with inflammatory bowel disease (IBD) over a 15-year period. A retrospective observational study investigated IBD patients operated on at an NHS Trust between 2000-2015, with follow-up data until 2020. Logistic regression models were used to determine the relationship between ethnic minority background and Index of Multiple Deprivation (IMD) on outcomes including requirement for intra-abdominal surgery, permanent stoma, re-do surgery and surgical complications, accounting for age, gender, smoking history and biologic treatment. There were 1,620 patients (56.7% ulcerative colitis (UC) and 43.3% Crohn's disease (CD)). Median age was 32 years, and 49.6% were female. Patients with an ethnic minority background accounted for 20.6%. Within 5 years of first presentation, 369 patients required intra-abdominal surgery, 95 permanent stomas and 107 re-do surgery. For CD patients, younger age at diagnosis, female patients, those with an ethnic minority background, higher IMD quintile, smoking history and biologic treatment were more likely to have intra-abdominal surgery. Ethnic minority background and higher IMD score were further associated with surgical complications for CD but not UC patients. Ethnic minority status and socioeconomic deprivation were associated with worse surgical outcomes within our cohort of IBD patients. These findings may stimulate discourse regarding the strategic planning of equitable healthcare services.

Identifiants

pubmed: 35554640
doi: 10.1007/s00384-022-04180-0
pii: 10.1007/s00384-022-04180-0
doi:

Substances chimiques

Biological Products 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1367-1374

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

GBD (2017) Inflammatory Bowel Disease Collaborators (2020) The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 5:17–30. https://doi.org/10.1016/S2468-1253(19)30333-4
doi: 10.1016/S2468-1253(19)30333-4
Frolkis AD, Dykeman J, Negrón ME, Debruyn J, Jette N, Fiest KM et al (2013) Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 145:996–1006. https://doi.org/10.1053/j.gastro.2013.07.041
doi: 10.1053/j.gastro.2013.07.041 pubmed: 23896172
Mao EJ, Hazlewood GS, Kaplan GG, Peyrin-Biroulet L, Ananthakrishnan AN (2017) Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther 45:3–13. https://doi.org/10.1111/apt.13847
doi: 10.1111/apt.13847 pubmed: 27862107
Baker DM, Folan AM, Lee MJ, Jones GL, Brown SR, Lobo AJ (2021) A systematic review and meta-analysis of outcomes after elective surgery for ulcerative colitis. Colorectal Dis 23:18–33. https://doi.org/10.1111/codi.15301
doi: 10.1111/codi.15301 pubmed: 32777171
Whelan G (1990) Epidemiology of inflammatory bowel disease. Med Clin North Am 74:1–12. https://doi.org/10.1016/S0025-7125(16)30581-8
doi: 10.1016/S0025-7125(16)30581-8 pubmed: 2404170
Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI et al (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390:2769–2778. https://doi.org/10.1016/S0140-6736(17)32448-0
doi: 10.1016/S0140-6736(17)32448-0 pubmed: 29050646
Misra R, Limdi J, Cooney R, Sakuma S, Brookes M, Fogden E et al (2019) Ethnic differences in inflammatory bowel disease: Results from the United Kingdom inception cohort epidemiology study. World J Gastroenterol 25:6145–6157. https://doi.org/10.3748/wjg.v25.i40.6145
doi: 10.3748/wjg.v25.i40.6145 pubmed: 31686769 pmcid: 6824277
Nahon S, Lahmek P, Macaigne G, Faurel JP, Sass C, Howaizi M et al (2009) Socioeconomic deprivation does not influence the severity of Crohn’s disease: Results of a prospective multicenter study. Inflamm Bowel Dis 15:594–598. https://doi.org/10.1002/ibd.20794
doi: 10.1002/ibd.20794 pubmed: 19085998
Godbole C, Bhangu A, Bowley DM, Subramanian T, Kamarajah SK, Karandikar S (2019) Impact of socioeconomic deprivation on short-term outcomes and long-term overall survival after colorectal resection for cancer. Int J Colorectal Dis 34:2101–2109. https://doi.org/10.1007/s00384-019-03431-x
doi: 10.1007/s00384-019-03431-x pubmed: 31713715
Pan D, Sze S, Minhas JS, Bangash MN, Pareek N, Divall P et al (2020) The impact of ethnicity on clinical outcomes in COVID-19: A systematic review. EClinicalMedicine 23:100404. https://doi.org/10.1016/j.eclinm.2020.100404
doi: 10.1016/j.eclinm.2020.100404 pubmed: 32632416 pmcid: 7267805
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344–349. https://doi.org/10.1016/j.jclinepi.2007.11.008
doi: 10.1016/j.jclinepi.2007.11.008
https://www.ethnicity-facts-figures.service.gov.uk/style-guide/writing-about-ethnicity
Tools N. https://tools.npeu.ox.ac.uk/imd
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
doi: 10.1097/01.sla.0000133083.54934.ae pubmed: 15273542 pmcid: 1360123
Nguyen GC, Bayless TM, Powe NR, Laveist TA, Brant SR (2007) Race and health insurance are predictors of hospitalized Crohn’s disease patients undergoing bowel resection. Inflamm Bowel Dis 13:1408–1416. https://doi.org/10.1002/ibd.20200
doi: 10.1002/ibd.20200 pubmed: 17567876
Benchimol EI, To T, Griffiths AM, Rabeneck L, Guttmann A (2011) Outcomes of pediatric inflammatory bowel disease: socioeconomic status disparity in a universal-access healthcare system. J Pediatr 158(960–7):e1-4. https://doi.org/10.1016/j.jpeds.2010.11.039
doi: 10.1016/j.jpeds.2010.11.039
Sewell JL, Velayos FS (2013) Systematic review: The role of race and socioeconomic factors on IBD healthcare delivery and effectiveness. Inflamm Bowel Dis 19:627–643. https://doi.org/10.1002/ibd.22986
doi: 10.1002/ibd.22986 pubmed: 22623078
Nguyen GC, Laveist TA, Gearhart S, Bayless TM, Brant SR (2006) Racial and geographic variations in colectomy rates among hospitalized ulcerative colitis patients. Clin Gastroenterol Hepatol 4:1507–1513. https://doi.org/10.1016/j.cgh.2006.09.026
doi: 10.1016/j.cgh.2006.09.026 pubmed: 17162242
Arsoniadis EG, Ho YY, Melton GB, Madoff RD, Le C, Kwaan MR (2017) African Americans and Short-Term Outcomes after Surgery for Crohn’s Disease: An ACS-NSQIP Analysis. J Crohns Colitis 11:468–473. https://doi.org/10.1093/ecco-jcc/jjw175
doi: 10.1093/ecco-jcc/jjw175 pubmed: 27683803
Montgomery SR Jr, Butler PD, Wirtalla CJ, Collier KT, Hoffman RL, Aarons CB et al (2018) Racial disparities in surgical outcomes of patients with Inflammatory Bowel Disease. Am J Surg 215:1046–1050. https://doi.org/10.1016/j.amjsurg.2018.05.011
doi: 10.1016/j.amjsurg.2018.05.011 pubmed: 29803499
Dos Santos Marques IC, Theiss LM, Wood LN, Gunnells DJ, Hollis RH, Hardiman KM et al (2021) Racial disparities exist in surgical outcomes for patients with inflammatory bowel disease. Am J Surg 221:668–674. https://doi.org/10.1016/j.amjsurg.2020.12.010
doi: 10.1016/j.amjsurg.2020.12.010 pubmed: 33309255
Gunnells DJ Jr, Morris MS, DeRussy A, Gullick AA, Malik TA, Cannon JA et al (2016) Racial Disparities in Readmissions for Patients with Inflammatory Bowel Disease (IBD) After Colorectal Surgery. J Gastrointest Surg 20:985–993. https://doi.org/10.1007/s11605-015-3068-9
doi: 10.1007/s11605-015-3068-9 pubmed: 26743885
Severs M, Spekhorst LM, Mangen MJ, Dijkstra G, Lowenberg M, Hoentjen F et al (2018) Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies. Inflamm Bowel Dis 24:1298–1306. https://doi.org/10.1093/ibd/izy004
doi: 10.1093/ibd/izy004 pubmed: 29688413
Lunney PC, Kariyawasam VC, Wang RR, Middleton KL, Huang T, Selinger CP et al (2015) Smoking prevalence and its influence on disease course and surgery in Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther 42:61–70. https://doi.org/10.1111/apt.13239
doi: 10.1111/apt.13239 pubmed: 25968332
Cosnes J, Gower-Rousseau C, Seksik P, Cortot A (2011) Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140:1785–1794. https://doi.org/10.1053/j.gastro.2011.01.055
doi: 10.1053/j.gastro.2011.01.055 pubmed: 21530745
Tan WP, Talbott VA, Leong QQ, Isenberg GA, Goldstein SD (2013) American Society of Anesthesiologists class and Charlson’s comorbidity index as predictors of postoperative colorectal anastomotic leak: a single-institution experience. J Surg Res 184:115–119. https://doi.org/10.1016/j.jss.2013.05.039
doi: 10.1016/j.jss.2013.05.039 pubmed: 23830360
Gustafsson CP, Gunnarsson U, Dahlstrand U, Lindforss U (2018) Loop-ileostomy reversal-patient-related characteristics influencing time to closure. Int J Colorectal Dis 33:593–600. https://doi.org/10.1007/s00384-018-2994-x
doi: 10.1007/s00384-018-2994-x pubmed: 29508050 pmcid: 5899111
Straus WL, Eisen GM, Sandler RS, Murray SC, Sessions JT (2000) Crohn’s disease: does race matter? The Mid-Atlantic Crohn’s Disease Study Group. Am J Gastroenterol 95:479–483. https://doi.org/10.1111/j.1572-0241.2000.t01-1-01531.x
doi: 10.1111/j.1572-0241.2000.t01-1-01531.x pubmed: 10685754
Kayal M, Saha A, Poojary P, Paramsothy S, Hirten R, Cohen L et al (2019) Emergent colectomy rates decreased while elective ileal pouch rates were stable over time: a nationwide inpatient sample study. Int J Colorectal Dis 34:1771–1779. https://doi.org/10.1007/s00384-019-03375-2
doi: 10.1007/s00384-019-03375-2 pubmed: 31512019 pmcid: 7060938
Zafar SN, Changoor NR, Williams K, Acosta RD, Greene WR, Fullum TM et al (2016) Race and socioeconomic disparities in national stoma reversal rates. Am J Surg 211:710–715. https://doi.org/10.1016/j.amjsurg.2015.11.020
doi: 10.1016/j.amjsurg.2015.11.020 pubmed: 26852146
Daluvoy S, Gonzalez F, Vaziri K, Sabnis A, Brody F (2008) Factors associated with ostomy reversal. Surg Endosc 22:2168–2170. https://doi.org/10.1007/s00464-008-0014-x
doi: 10.1007/s00464-008-0014-x pubmed: 18626708
Barnes EL, Loftus EV Jr, Kappelman MD (2021) Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases. Gastroenterology 160:677–689. https://doi.org/10.1053/j.gastro.2020.08.064
doi: 10.1053/j.gastro.2020.08.064 pubmed: 33098884
Kilbourne AM, Switzer G, Hyman K, Crowley-Matoka M, Fine MJ (2006) Advancing health disparities research within the health care system: a conceptual framework. Am J Public Health 96:2113–2121. https://doi.org/10.2105/AJPH.2005.077628
doi: 10.2105/AJPH.2005.077628 pubmed: 17077411 pmcid: 1698151
Nguyen GC, LaVeist TA, Harris ML, Wang MH, Datta LW, Brant SR (2010) Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. Am J Gastroenterol 105:2202–2208. https://doi.org/10.1038/ajg.2010.202
doi: 10.1038/ajg.2010.202 pubmed: 20485281 pmcid: 3170037
Nguyen GC, LaVeist TA, Harris ML, Datta LW, Bayless TM, Brant SR (2009) Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis 15:1233–1239. https://doi.org/10.1002/ibd.20883
doi: 10.1002/ibd.20883 pubmed: 19177509
Tormey LK, Farraye FA, Paasche-Orlow MK (2016) Understanding Health Literacy and its Impact on Delivering Care to Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 22:745–751. https://doi.org/10.1097/MIB.0000000000000622
doi: 10.1097/MIB.0000000000000622 pubmed: 26595554
Nerich V, Monnet E, Weill A, Vallier N, Vanbockstael V, Auleley GR et al (2010) Fine-scale geographic variations of inflammatory bowel disease in France: correlation with socioeconomic and house equipment variables. Inflamm Bowel Dis 16:813–821. https://doi.org/10.1002/ibd.21122
doi: 10.1002/ibd.21122 pubmed: 19902547
Abegunde AT, Muhammad BH, Bhatti O, Ali T (2016) Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World J Gastroenterol 22:6296–6317. https://doi.org/10.3748/wjg.v22.i27.6296
doi: 10.3748/wjg.v22.i27.6296 pubmed: 27468219 pmcid: 4945988
Nargis N, Yong HH, Driezen P, Mbulo L, Zhao L, Fong GT et al (2019) Socioeconomic patterns of smoking cessation behavior in low and middle-income countries: Emerging evidence from the Global Adult Tobacco Surveys and International Tobacco Control Surveys. PLoS ONE 14:e0220223. https://doi.org/10.1371/journal.pone.0220223.eCollection
doi: 10.1371/journal.pone.0220223.eCollection pubmed: 31490958 pmcid: 6730869

Auteurs

Dimitrios Stamatiou (D)

University Hospitals Birmingham NHS Foundation Trust, Colorectal Surgery Unit, Birmingham, UK.

David N Naumann (DN)

University Hospitals Birmingham NHS Foundation Trust, Colorectal Surgery Unit, Birmingham, UK.
University of Birmingham, Birmingham, UK.

Helen Foss (H)

University Hospitals Birmingham NHS Foundation Trust, Colorectal Surgery Unit, Birmingham, UK.

Rishi Singhal (R)

Upper GI & Bariatric Surgery Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Sharad Karandikar (S)

University Hospitals Birmingham NHS Foundation Trust, Colorectal Surgery Unit, Birmingham, UK. sharad.karandikar@uhb.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH